S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 86 100 KRW 0.94% Market Closed
Market Cap: 1.7T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is 103 373.34 KRW. Compared to the current market price of 86 100 KRW, ST Pharm Co Ltd is Undervalued by 17%.

Intrinsic Value
103 373.34 KRW
Undervaluation 17%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
ST Pharm Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ST Pharm Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ST Pharm Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ST Pharm Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

86 100 KRW
+0.94%
+0.94%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

ST Pharm Co Ltd
KR
Life Sciences Tools & Services
Market Cap
1.6T KRW
IPO
Jun 23, 2016
Employees
-
Korea
Market Cap
1.6T KRW
Industry
Life Sciences Tools & Services
IPO
Jun 23, 2016
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about ST Pharm Co Ltd

Provide an overview of the primary business activities
of ST Pharm Co Ltd.

What unique competitive advantages
does ST Pharm Co Ltd hold over its rivals?

What risks and challenges
does ST Pharm Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ST Pharm Co Ltd.

Provide P/S
for ST Pharm Co Ltd.

Provide P/E
for ST Pharm Co Ltd.

Provide P/OCF
for ST Pharm Co Ltd.

Provide P/FCFE
for ST Pharm Co Ltd.

Provide P/B
for ST Pharm Co Ltd.

Provide EV/S
for ST Pharm Co Ltd.

Provide EV/GP
for ST Pharm Co Ltd.

Provide EV/EBITDA
for ST Pharm Co Ltd.

Provide EV/EBIT
for ST Pharm Co Ltd.

Provide EV/OCF
for ST Pharm Co Ltd.

Provide EV/FCFF
for ST Pharm Co Ltd.

Provide EV/IC
for ST Pharm Co Ltd.

Show me price targets
for ST Pharm Co Ltd made by professional analysts.

What are the Revenue projections
for ST Pharm Co Ltd?

How accurate were the past Revenue estimates
for ST Pharm Co Ltd?

What are the Net Income projections
for ST Pharm Co Ltd?

How accurate were the past Net Income estimates
for ST Pharm Co Ltd?

What are the EPS projections
for ST Pharm Co Ltd?

How accurate were the past EPS estimates
for ST Pharm Co Ltd?

What are the EBIT projections
for ST Pharm Co Ltd?

How accurate were the past EBIT estimates
for ST Pharm Co Ltd?

Compare the revenue forecasts
for ST Pharm Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ST Pharm Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ST Pharm Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of ST Pharm Co Ltd compared to its peers.

Compare the P/E ratios
of ST Pharm Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing ST Pharm Co Ltd with its peers.

Analyze the financial leverage
of ST Pharm Co Ltd compared to its main competitors.

Show all profitability ratios
for ST Pharm Co Ltd.

Provide ROE
for ST Pharm Co Ltd.

Provide ROA
for ST Pharm Co Ltd.

Provide ROIC
for ST Pharm Co Ltd.

Provide ROCE
for ST Pharm Co Ltd.

Provide Gross Margin
for ST Pharm Co Ltd.

Provide Operating Margin
for ST Pharm Co Ltd.

Provide Net Margin
for ST Pharm Co Ltd.

Provide FCF Margin
for ST Pharm Co Ltd.

Show all solvency ratios
for ST Pharm Co Ltd.

Provide D/E Ratio
for ST Pharm Co Ltd.

Provide D/A Ratio
for ST Pharm Co Ltd.

Provide Interest Coverage Ratio
for ST Pharm Co Ltd.

Provide Altman Z-Score Ratio
for ST Pharm Co Ltd.

Provide Quick Ratio
for ST Pharm Co Ltd.

Provide Current Ratio
for ST Pharm Co Ltd.

Provide Cash Ratio
for ST Pharm Co Ltd.

What is the historical Revenue growth
over the last 5 years for ST Pharm Co Ltd?

What is the historical Net Income growth
over the last 5 years for ST Pharm Co Ltd?

What is the current Free Cash Flow
of ST Pharm Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for ST Pharm Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ST Pharm Co Ltd

Current Assets 348.4B
Cash & Short-Term Investments 90.1B
Receivables 122.6B
Other Current Assets 135.7B
Non-Current Assets 327.1B
Long-Term Investments 17.7B
PP&E 280.1B
Intangibles 13.5B
Other Non-Current Assets 15.7B
Current Liabilities 83.7B
Accounts Payable 17.7B
Accrued Liabilities 8.3B
Short-Term Debt 20.9B
Other Current Liabilities 36.9B
Non-Current Liabilities 207.1B
Long-Term Debt 161.8B
Other Non-Current Liabilities 45.3B
Efficiency

Earnings Waterfall
ST Pharm Co Ltd

Revenue
278.6B KRW
Cost of Revenue
-181.4B KRW
Gross Profit
97.2B KRW
Operating Expenses
-70.8B KRW
Operating Income
26.4B KRW
Other Expenses
5.9B KRW
Net Income
32.4B KRW

Free Cash Flow Analysis
ST Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

ST Pharm Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
ROE is Increasing
47/100
Profitability
Score

ST Pharm Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ST Pharm Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
61/100
Solvency
Score

ST Pharm Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ST Pharm Co Ltd

Wall Street analysts forecast ST Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 124 440 KRW with a low forecast of 101 000 KRW and a high forecast of 136 500 KRW.

Lowest
Price Target
101 000 KRW
17% Upside
Average
Price Target
124 440 KRW
45% Upside
Highest
Price Target
136 500 KRW
59% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ST Pharm Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ST Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one ST Pharm Co Ltd stock?

The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is 103 373.34 KRW.

Is ST Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 86 100 KRW, ST Pharm Co Ltd is Undervalued by 17%.

Back to Top